Xinjiani Chen

Xinjiani Chen

Auto-generated profile, based on publicly available information

Xinjiani Chen

College of Medicine, Jiaxing University Department of Pharmaceutics Jiaxing, Zhejiang, 314001, P. R

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
Bailei LiBailei Li
Bailei Li
SSSuxian Song
Suxian Song
YZYu Zhou
Yu Zhou
XCXinjiani Chen
Xinjiani Chen
Zhen ZhangZhen Zhang
Zhen Zhang
RZRongqing Zhang
Rongqing Zhang

11 November 2025 in Advanced Science
Verified
Journal Article
Open access
Bailei LiBailei Li
Bailei Li
Ruixue AiRuixue Ai
Ruixue Ai
XCXinjiani Chen
Xinjiani Chen
YWYaning Wang
Yaning Wang
CPChenlei Pan
Chenlei Pan
RZRongqing Zhang
Rongqing Zhang
Dental restorative materials remain constrained by clinical unmet needs in biomechanical durability, bioactivity, and long‐term tissue integration, despite incremental advances in conventional ceramics and polymers. Addressing these gaps requires functional innovation. Multiscale design strategies bridge atomic‐level material engineering with macroscopic clinical performance. This review highlights transformative approaches, including bioinspired architectures (e.g., decellularized extracellular matrix scaffolds) that replicate native oral tissue mechanics while promoting cell‐driven remodeling, and smart interfaces (e.g., pH‐responsive polymers) for dynamic biofilm suppression. Functional enhancements are achieved via 3D printing for anatomically precise restorations, nanotechnology for crack‐resistant ceramics, and surface functionalization (e.g., graphene oxide coatings) to accelerate osseointegration. Emerging paradigms such as 4D‐printed shape‐memory composites and artificial intelligence (AI)‐driven inverse design further exemplify innovation by enabling self‐adapting materials and accelerated discovery of bioactive formulations. Critically, barriers are analyzed to clinical translation, including scalable manufacturing of hierarchical structures, mitigating biodegradation in aggressive oral environments, and balancing cost‐effectiveness with performance. By integrating mechanistic insights with clinical translation, this work provides a blueprint for next‐generation functional dental materials that reconcile laboratory innovation with real‐world clinical demands.

24 May 2024 in Cells
Verified
Journal Article
Open access
PDF file
XCXinjiani Chen
Xinjiani Chen
NYNing Yang
Ning Yang
Bailei LiBailei Li
Bailei Li
XGXinyu Gao
Xinyu Gao
YWYayu Wang
Yayu Wang
RZRongqing Zhang
Rongqing Zhang
Small extracellular vesicles were shown to have similar functional roles to their parent cells without the defect of potential tumorigenicity, which made them a great candidate for regenerative medicine. The last twenty years have witnessed the rapid development of research on small extracellular vesicles. In this paper, we employed a scientometric synthesis method to conduct a retrospective analysis of small extracellular vesicles in the field of bone-related diseases. The overall background analysis consisted the visualization of the countries, institutions, journals, and authors involved in research. The current status of the research direction and future trends were presented through the analysis of references and keywords, which showed that engineering strategies, mesenchymal stem cell derived exosomes, and cartilage damage were the most concerning topics, and scaffold, osteoarthritis, platelet-rich plasma, and senescence were the future trends. We also discussed the current problems and challenges in practical applications, including the in-sight mechanisms, the building of relevant animal models, and the problems in clinical trials. By using CiteSpace, VOSviewer, and Bibliometrix, the presented data avoided subjective selectivity and tendency well, which made the conclusion more reliable and comprehensive. We hope that the findings can provide new perspectives for researchers to understand the evolution of this field over time and to search for novel research directions.

Verified
Journal Article
Open access
PDF file
YWYayu Wang
Yayu Wang
QWQin Wang
Qin Wang
XCXinjiani Chen
Xinjiani Chen
Bailei LiBailei Li
Bailei Li
Zhen ZhangZhen Zhang
Zhen Zhang
RZRongqing Zhang
Rongqing Zhang
The frequent occurrence of viral infections poses a serious threat to human life. Identifying effective antiviral components is urgent. In China, pearls have been important traditional medicinal ingredients since ancient times, exhibiting various therapeutic properties, including detoxification properties. In this study, a peptide, KKCH, which acts against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was derived from Pinctada fucata pearls. Molecular docking showed that it bound to the same pocket of the SARS-CoV-2 S protein and cell surface target angiotensin-converting enzyme II (ACE2). The function of KKCH was analyzed through surface plasmon resonance (SPR), Enzyme-Linked Immunosorbent Assays, immunofluorescence, and simulation methods using the SARS-CoV-2 pseudovirus and live virus. The results showed that KKCH had a good affinity for ACE2 (KD = 6.24 × 10−7 M) and could inhibit the binding of the S1 protein to ACE2 via competitive binding. As a natural peptide, KKCH inhibited the binding of the SARS-CoV-2 S1 protein to the surface of human BEAS-2B and HEK293T cells. Moreover, viral experiments confirmed the antiviral activity of KKCH against both the SARS-CoV-2 spike pseudovirus and SARS-CoV-2 live virus, with half-maximal inhibitory concentration (IC50) values of 398.1 μM and 462.4 μM, respectively. This study provides new insights and potential avenues for the prevention and treatment of SARS-CoV-2 infections.

29 June 2026 in Regenerative Biomaterials
Verified
Journal Article
Open access
XCXinjiani Chen
Xinjiani Chen
BLBailei Li
Bailei Li
WGWenxue Gu
Wenxue Gu
MLMingjuan Li
Mingjuan Li
Zhen ZhangZhen Zhang
Zhen Zhang
The secretome of human umbilical cord mesenchymal stem cells (hUC-MSCs) represents a promising cell-free therapeutic approach for wound healing because of its rich composition of bioactive factors that promote tissue repair. However, the clinical translation of secretome-based therapies is hindered by the instability of its bioactive components during storage. To address this challenge, we developed a lyophilization strategy using cryoprotectants to produce a stable, powdered form of hUC-MSC-conditioned medium (CM). Our results demonstrated that the lyophilized CM (Lyo-CM), particularly when formulated with specific cryoprotectants, maintained excellent bioactivity of CM while showing superior reproducibility and stability. Furthermore, both in vitro and in vivo experiments revealed that Lyo-CM significantly enhanced wound closure during inflammation and proliferation phases, including inflammation resolution, cell proliferation, angiogenesis, and extracellular matrix remodeling. Our study provides a valuable approach to establish a clinically viable, shelf-stable formulation of hUC-MSC secretome to advance the field of cell-free regenerative therapy.